Detalhe da pesquisa
1.
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.
Int J Neuropsychopharmacol
; 25(4): 269-279, 2022 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35022754
2.
Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.
Int J Neuropsychopharmacol
; 23(9): 549-558, 2020 12 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32367114
3.
Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder.
Neuroimage
; 118: 1-12, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26032890
4.
Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
Int J Neuropsychopharmacol
; 18(8)2015 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25820840
5.
Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography.
Acta Neuropsychiatr
; 27(3): 143-52, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25600154
6.
Neural correlates of suicidal ideation and its reduction in depression.
Int J Neuropsychopharmacol
; 18(1)2014 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-25550331
7.
Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Int J Neuropsychopharmacol
; 18(1)2014 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-25539512
8.
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.
Depress Anxiety
; 31(4): 297-307, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24353110
9.
Biomarkers in mood disorders research: developing new and improved therapeutics.
Rev Psiquiatr Clin
; 41(5): 131-134, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-26082563
10.
Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
Int J Neuropsychopharmacol
; 16(10): 2195-208, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23809145
11.
Baseline mood-state measures as predictors of antidepressant response to scopolamine.
Psychiatry Res
; 196(1): 62-7, 2012 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-22349648
12.
The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.
Curr Opin Neurol
; 24(4): 364-70, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21725241
13.
Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.
J Affect Disord
; 279: 239-249, 2021 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33074143
14.
The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions.
Adv Pharmacol
; 89: 357-386, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32616213
15.
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Biol Psychiatry Cogn Neurosci Neuroimaging
; 4(7): 610-618, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30826253
16.
Neural basis of abnormal response to negative feedback in unmedicated mood disorders.
Neuroimage
; 42(3): 1118-26, 2008 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18586109
17.
Selective effects of cholinergic modulation on task performance during selective attention.
Neuropsychopharmacology
; 33(4): 913-23, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17534379
18.
Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
Neuroimage Clin
; 20: 92-101, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30094160
19.
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Arch Gen Psychiatry
; 63(10): 1121-9, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17015814
20.
Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedonia.
Behav Res Ther
; 97: 170-177, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28806614